Ken Myszkowski
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ken Myszkowski
Earlier roles on record: CFO at Arrowhead Pharmaceuticals, Inc. (ARWR) until May 13, 2025. Arrowhead Pharmaceuticals, Inc. reported in an 8-K filed April 15, 2025 that Ken Myszkowski retired as Chief Financial Officer, effective May 13, 2025. Ken Myszkowski has spoken on 19 earnings calls across 1 company, most recently for Arrowhead Pharmaceuticals, Inc. on February 10, 2025.
“On, April 9, 2025 Ken Myszkowski notified Arrowhead Pharmaceuticals, Inc. (the "Company") of his decision to retire as Chief Financial Officer of the Company, effective as of May 13, 2025 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-05-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.